This company seems to have been delisted
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
KemPharm
KMPH
C$8.00
Share price
-0.34%
Change (1 day)
5.98%
Change (1 year)
Categories
KemPharm (KMPH) - Total debt
Total debt on the balance sheet as of December 2022 : C$31.82 Million
According to KemPharm's latest financial reports the company's total debt is C$31.82 Million. A company’s total debt is the sum of all current and non-current debts.
KemPharm - Total debt on balance sheet (from 2014 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | C$31.36 M | 1429.75% |
| 2021-12-31 | C$2.05 M | -97.72% |
| 2020-12-31 | C$89.95 M | -13.4% |
| 2019-12-31 | C$0.10 B | -7.07% |
| 2018-12-31 | C$0.11 B | -4.9% |
| 2017-12-31 | C$0.11 B | -4.24% |
| 2016-12-31 | C$0.12 B | 283.02% |
| 2015-12-31 | C$32.04 M | 52.16% |
| 2014-12-31 | C$21.05 M | 398.3% |
| 2013-12-31 | C$4.22 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Jazz Pharmaceuticals JAZZ | C$7.46 B | 23,344.65% | 🇮🇪 Ireland |
 Agile Therapeutics
AGRX | C$0.39 M | -98.75% | 🇺🇸 USA |
 Theravance Biopharma
TBPH | C$66.3 M | 108.31% | Cayman Islands |
 ANI Pharmaceuticals ANIP | C$0.85 B | 2,594.22% | 🇺🇸 USA |